Trial Profile
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Secondary hyperparathyroidism
- Focus Pharmacodynamics
- 03 Nov 2014 New trial record